Image
27.02.2024
New findings from our research into diabetes and disordered eating
We’ve rounded up the findings from two vital research projects we funded to help treat and prevent eating...
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.
Read more